Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
Also known as: Monomorphic Epiteliotrophic Intestinal T-cell Lymphoma / Monomorphic epitheliotropic intestinal T-cell lymphoma (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00928 | Azacitidine | 1 | Withdrawn | 1 |
DB00997 | Doxorubicin | 1 | Withdrawn | 1 |
DB11952 | Duvelisib | 1 | Withdrawn | 1 |
DB06176 | Romidepsin | 1 | Withdrawn | 1 |
DB18617 | WU-CART-007 | 1 | Recruiting | 1 |
DB18258 | DR-01 | 1 / 2 | Recruiting | 1 |
DB00928 | Azacitidine | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB00997 | Doxorubicin | 2 | Recruiting | 1 |
DB11952 | Duvelisib | 2 | Recruiting | 1 |
DB00773 | Etoposide | 2 | Recruiting | 1 |
DB00635 | Prednisone | 2 | Recruiting | 1 |
DB00541 | Vincristine | 2 | Recruiting | 1 |